LipoScience seeks FDA clearance for cardiovascular testing device

02/1/2010 | American City Business Journals

LipoScience has filed an application with the FDA seeking clearance for Vantera, a device that would enable research laboratories to conduct on-site testing of blood samples for risks of heart diseases. CEO Rick Brajer said he is hopeful the company can secure FDA clearance later this year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ